Metabolite Reference Standards and Reagents: Request Available Compounds
Click the Common Name to see compound details, download synthesis reports, and request completed compounds.
Search:
Fields searched: | Browse by Pathway Cassette |
Structure | Common Name | InChiKey | Isotopic Label Type | Isotopic Label Position | Pathway Cassette | MSSC | Status | Request this compound |
---|---|---|---|---|---|---|---|---|
5-formylcytosine | FHSISDGOVSHJRW-UHFFFAOYSA-N | Epigenetics | SRI | completed | ||||
Malioxamycin | KXQRAPMNPUXYGT-VDTYLAMSSA-N | Miscellaneous/drugs | RTI | completed | ||||
(6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic acid, chloride | NDMWNIVQVBEIJX-ZEDZUCNESA-N | Folates/1C metabolism | RTI | completed ‡ | ||||
2-keto-3-deoxygluconate | WPAMZTWLKIDIOP-WVZVXSGGSA-N | Miscellaneous/drugs | SRI | completed | ||||
11-keto-1,6,7-trideuterotestosterone | WTPMRQZHJLJSBO-FLDABYKKSA-N | Steroids/bioactive lipids | RTI | completed | ||||
5-Formimino-tetrahydrofolic acid | YCWUVLPMLLBDCU-OLZOCXBDSA-N | Folates/1C metabolism | RTI | completed ‡ | ||||
10-Formyl-tetrahydrofolic acid | AUFGTPPARQZWDO-YUZLPWPTSA-N | Folates/1C metabolism | RTI | completed | ||||
5-carboxylcytosine | BLQMCTXZEMGOJM-UHFFFAOYSA-N | Epigenetics | SRI | completed | ||||
1-Monoethyl malate | FHHFKGGCXNOIAY-PTQBSOBMSA-N | 13C | 1 position of malate | Krebs cycle | SRI | completed | ||
Dimethyl α-ketoglutarate | TXIXSLPEABAEHP-UHFFFAOYSA-N | 13C | 1,2,3,4,5-13C5 | Krebs cycle | RTI | completed | ||
Itaconic acid | LVHBHZANLOWSRM-UHFFFAOYSA-N | 13C | uniform enrichment though any 2 positions also would suffice | Krebs cycle | SRI | completed | ||
2-hydroxyglutaric acid | HWXBTNAVRSUOJR-UHFFFAOYSA-N | 13C | uniform enrichment | Krebs cycle | SRI | completed | ||
13CD3-QA Iodide | CSRAQSNOQWXULC-HBKQTYJLSA-M | 13C + 2H | both on one mehyl group | Reagents | SRI | completed | ||
15N-Cholamine Bromide | VSZWLDAGOXQHNB-NWZHYJCUSA-M | 15N | Please see Anal Chem. 2013 Sep 17;85(18):8715-21. | Reagents | SRI | completed | ||
15NQDA | CSRAQSNOQWXULC-XOJMRSMASA-M | 15N | 2-15Naminooxyethyl | Reagents | SRI | completed | ||
[15N2,13C]-5-Carboxycytosine | BLQMCTXZEMGOJM-QIOHBQFSSA-N | 15N, 13C | SRI | completed | ||||
[15N2,13C]-5-Formylcytosine | FHSISDGOVSHJRW-QIOHBQFSSA-N | 15N, 13C | SRI | completed | ||||
Fructose-6-phosphate | BGWGXPAPYGQALX-ARQDHWQXSA-N | 13C | uniform enrichment | Glycolysis | SRI | completed | ||
(S)-4,5-Dihydroorotic-4,5,6,carboxy-13C4 acid | UFIVEPVSAGBUSI-UHFFFAOYSA-N | 13C | Nucleotide pathways: pyrimidine biosynthesis | RTI | completed | |||
6-phosphogluconolactone | IJOJIVNDFQSGAB-SQOUGZDYSA-N | 13C | uniform enrichment | Pentose phosphate: oxidative branch | SRI | completed | ||
D-Ribulose 5-phosphate | FNZLKVNUWIIPSJ-UHNVWZDZSA-N | 13C | uniform enrichment | Pentose phosphate: oxidative branch | SRI | completed | ||
Orotic-4,5,6-carboxy-13C4 Acid Monohydrate | PXQPEWDEAKTCGB-UHFFFAOYSA-N | 13C | Nucleotide pathways: pyrimidine biosynthesis | RTI | completed | |||
D-Ribose 5-phosphate | KTVPXOYAKDPRHY-SOOFDHNKSA-N | 13C | uniform enrichment | Pentose phosphate: non-oxidative branch | SRI | completed | ||
6-phosphogluconic acid | BIRSGZKFKXLSJQ-SQOUGZDYSA-N | 13C | uniform enrichment | Pentose phosphate: oxidative branch | SRI | completed | ||
glucose-6-phosphate | NBSCHQHZLSJFNQ-GASJEMHNSA-N | 13C | uniform enrichment | Glycolysis | SRI | completed | ||
U13C-AICA Ribonucleotide | NOTGFIUVDGNKRI-UUOKFMHZSA-N | 13C | Nucleotide pathways: purine biosynthesis | RTI | completed | |||
Carbamoyl phosphate | FFQKYPRQEYGKAF-UHFFFAOYSA-N | 13C, 15N | Nucleotide pathways: pyrimidine biosynthesis | RTI | completed | |||
11β-Hydroxyandrostenedione-d3 | 2H | carbons 1,6,7 | Steroids/bioactive lipids | RTI | completed ‡ | |||
3-Deoxyarabino-hexonic acid | YGMNHEPVTNXLLS-VAYJURFESA-N | NA | NA | Miscellaneous/drugs | SRI | completed | ||
alpha-ketoisocaproate-13C6 | t | t | t | branched-chain amino acid oxidation | completed | |||
alpha-keto-beta-methylvalerate-13C6 | t | t | t | branched-chain amino acid oxidation | completed | |||
QDA Iodide | CSRAQSNOQWXULC-UHFFFAOYSA-M | unlabelled parent * | Reagents | SRI | completed | |||
Cholamine Bromide | VSZWLDAGOXQHNB-UHFFFAOYSA-M | unlabelled parent * | Reagents | SRI | completed * | |||
AICA Ribonucleotide | XOGIBYSEXZJKHY-UIPKGFOGSA-N | unlabelled parent * | Nucleotide pathways: purine biosynthesis | RTI | completed * | |||
11β-Hydroxyandrostenedione | WSCUHXPGYUMQEX-KCZNZURUSA-N | unlabelled parent * | Steroids/bioactive lipids | RTI | completed * | |||
Dimethyl α-ketoglutarate | TXIXSLPEABAEHP-UHFFFAOYSA-N | unlabelled parent * | Krebs cycle | RTI | completed * | |||
(6R,S)-5,10-Methylene-5,6,7,8-tetrahydrofolic acid, calcium salt | AKUPTUNGFOADRT-ZEDZUCNESA-L | unlabelled parent * | Folates/1C metabolism | RTI | completed * |
Number of records: 37
* This non-target unlabelled compound was analyzed by chromatographic and spectral methods as appropriate but was not certified by GLP protocols.
† One of more compounds were approved for synthesis based on this nomination. Click the common name for details.
‡ This compound was approved for synthesis based on the nomination of a different compound, or a nomination that was not specific.